Treat Obesity as a Risk Factor, not a Prerequisite for Pediatric T2D Screening
About one-quarter of children with T2D are not obese, according to a meta-analysis, making comprehensive screening essential in the population.
Variable BMI Pattern in Midlife May Serve as Indicator for Dementia in Late Life
Variable BMI patterns across the lifespan may be a prodromal marker of dementia; a pattern of midlife increase followed by decrease was associated with greatest risk.
Daily Dose: Concomitant Gestational Diabetes, Hypertensive Disorder Raise Long-term Postpartum CVD Risk
Your daily dose of clinical news you may have missed.
5 New Drugs Approved for Primary Care: Q4 2022
The end of another quarter means a new list of FDA-approved drugs for conditions treated in primary care. Are you up-to-date? Click through to find out.
She Treats Long COVID and Got it Herself: This Physiatrist Advocates for Federal Research and Patient Support
Physiatrist Monica Verduzco-Gutierrez, MD, highlights the state of long COVID management in the US and says primary care is crucial in diagnosing and treating the new condition.
Topics in Cardiometabolic Disease: Hypertension Guideline Quiz
Cardiometabolic disease affects 1 out of every 2 Americans today. This first of 4 quizzes tests your knowledge of how to manage hypertension, heart failure, and renal disease.
Global Burden of Cardiovascular Disease, Risk Factors Detailed in New American College of Cardiology Report
Worldwide the report finds that hypertension, hypercholesterolemia, dietary risks, and air pollution are the leading causes of CVD which remains the leading cause of death globally.
FDA Clears Dexcom G7 CGM System for Persons with T1D and T2D
The Dexcom G7 continuous glucose monitoring system provides an overall MARD of 8.2%, the highest of any FDA-cleared CGM, the company says.
Daily Dose: Statin Treatment, Duration Linked to Reduced Risk of Hemorrhagic Stroke
COVID-19 Vaccines Have Saved 3 Million Lives in the 2 Years Since the First EUA
The vaccination campaign in the US also has prevented more than 18 million hospitalizations and saved $1 trillion in medical costs, according to a modeling study.
Concomitant Gestational Diabetes and Hypertensive Disorder Increase Long-term Postpartum CVD Risk
Having both conditions while pregnant in the current study conferred more than double the risk of future CVD vs having either condition alone.
Empagliflozin Reduces HbA1c, FPG in Pediatric Population with Type 2 Diabetes
Empagliflozin is the first SGLT-2 inhibitor to demonstrate a statistically significant reduction in HbA1c in children and adolescents with type 2 diabetes.
9 Indicators of Personal Stress and How the 50 States Rank
From crime rates and credit scores to average health and hours worked in a week, find the 5 states that rank highest and the 5 lowest across 9 composite measures of stress.
Dementia: New Screening Tool to be Evaluated in Primary Care
The NIH has awarded $11 million for evaluation of a 5-minute, largely visual screening test for dementia intended for use in primary care practice.
Statin Treatment and Duration Associated with Reduced Risk of Hemorrhagic Stroke
Similar reduction in risk was reported for both lobar and nonlobar intracranial hemorrhage with longer statin treatment associated with greater protection, according to Danish investigators.
Daily Dose: Pediatric Obesity Treatment
FDA Grants Priority Review to Pfizer’s RSV Vaccine Candidate for Older Americans
The FDA has granted priority review to a biologics license application for Pfizer’s respiratory syncytial virus vaccine candidate, RSVpreF, for adults aged ≥60 years.
FDA Authorizes Bivalent COVID-19 Vaccines as Booster Dose in Children Aged 6 Months to 5 Years
The FDA amended Pfizer and Moderna EUAs for updated COVID-19 vaccines to include children as young as age 6 months as holidays and winter weather approach.
Respiratory Virus Season Update: By the Numbers
Bempedoic Acid Meets Primary Endpoint in Key Cardiovascular Outcomes Trial: CLEAR
Approved in 2020 as Nexletol, bempedoic acid as the first ATP citrate lyase inhibitor and oral non-statin therapy to meet the MACE-4 primary endpoint.
